AwardedCzechiaGoodsCZK 48,741,000
Dodávky léků – AVTOZMA 2026
- Published
- Published 20 March 2026
- Deadline
- Closed 20 April 2026
Overview
The Rheumatology Institute procured continuous supplies of tocilizumab medication (pharmaceutical goods, CPV 33652000) with an estimated value of 48,741,000 CZK. The contract was awarded to PROMEDICA PRAHA GROUP, a.s. on 5 May 2026 for the full estimated value.
Key details
- Country
- Czechia
- Status
- Awarded
- Category
- Goods
- Estimated value
- CZK 48,741,000
- Procedure
- Open
- Published
- 20 March 2026
- Deadline
- Closed
Antineoplastic and immunomodulating agents
Award outcome
- Awarded value
- CZK 48,741,000
- Award date
- 5 May 2026
- Contract period
- — → 19 April 2029
- PROMEDICA PRAHA GROUP, a.s.
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
8 May 2026
Contract Notice
16 April 2026
Contract Notice
20 March 2026
Contracting authority
Revmatologický ústav
Procuring entityPraha, Czechia
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.